| Welcome to the new Journal of Business Chemistry! |
Jens Leker, Lars Hahn, Stefan Picker, Carsten Vehring |
Letter from the Editor |
2004-05 |
| Enhancing market-oriented R&D planning by integrated market and patent portfolios |
Holger Ernst, Bernd Fabry, Jan Henrik Soll |
Research Paper |
2004-05 |
| Intellectual capital and competitive advantages: the case of TTY Biopharm Company |
Ming-Chin Chen |
Research Paper |
2004-05 |
| Accelerating the Processes of Innovation: Degussa's New Bonus System Creates Innovation Incentives for Creavis Employees |
Hans Höcker, Hans-Jürgen Nettelnbreker |
Practitioner’s Section |
2004-05 |
| Running into Business! |
Jens Leker, Lars Hahn, Stefan Picker, Carsten Vehring |
Letter from the Editor |
2004-09 |
| Organising Product Stewardship in Large Chemical Companies |
Manfred Fleischer, Michael Troege |
Research Paper |
2004-09 |
| Virtual Communities as an Organizational Mechanism for Embedding Knowledge in Drug Discovery: The Case of Chemical Biology Platform |
Vadake K. Narayanan, Frank Douglas, Daniel Schirlin, Gunther Wess, Dennis Geising |
Research Paper |
2004-09 |
| The Human Side of Innovation |
Alexander Ditze, Peter Schmidt, Juan-Carlos Wuhrmann, Thomas Müller-Kirschbaum |
Practitioner’s Section |
2004-09 |
| Why are scientists not managers!? The Importance of Interdisciplinary Skills in Business and Science |
Stefan Picker, Carsten Vehring, Lars Hahn, Madeleine Vala, Jens Leker |
Letter from the Editor |
2005-01 |
| Condiment paprika research in Australia |
Nicholas F. Derera, Natalia Nagy, Adriana Hoxha |
Research Paper |
2005-01 |
| Chemicals Regulation and the Porter Hypothesis A Critical Review of the New European Chemicals Regulation |
Torsten Frohwein, Bernd Hansjürgens |
Research Paper |
2005-01 |
| Futuring in the European Chemical Industry |
Klaus Heinzelbecker |
Practitioner’s Section |
2005-01 |
| Defining "Business Chemistry" |
Stefan Picker, Madeleine Vala, Lars Hahn, Carsten Vehring, Jens Leker |
Letter from the Editor |
2005-05 |
| Internationalisation of SMEs: A Micro-Economic Approach |
Jan Smolarski, Neil Wilner |
Research Paper |
2005-05 |
| “Sensory Fit Panel” – Development of a new Advertising Claim Support method to assess aesthetic diaper fit performance in an objective, reliable and reproducible way |
Claudia Liedtke, Iris Christ, Frank Wiesemann |
Research Paper |
2005-05 |
| High-Performance Research for High-Tech Materials |
Andreas Gutsch, Michael Dröscher |
Practitioner’s Section |
2005-05 |
| Trends in Biotechnology - Opportunities and Threats for Developing Countries!? |
Stefan Picker, Beatriz Garcia |
Letter from the Editor |
2005-09 |
| Different Rhythms of Health Biotechnology Development in Brazil and Cuba |
Halla Thorsteinsdóttir, Tirso W. Sáenz, Peter A. Singer, Abdallah S. Daar |
Commentary |
2005-09 |
| Streptomyces as a host for the secretion of heterologous proteins for the production of biopharmaceuticals |
Carlos Vallin, Elsa Pimienta, Astrid Ramos, Caridad Rodriguez, Lieve Van Mellaert, Jozef Anné |
Research Paper |
2005-09 |
| Science and Society in Cuba in the Context of Techno-economic Globalization |
Aqueil Ahmad |
Research Paper |
2005-09 |
| Propolis: Patents and technology trends for health applications |
Dámarys Suárez, Daniel Zayas, Frenkel Guisado |
Research Paper |
2005-09 |
| Future Studies in Brazil CGEE Approach for Bio- and Nanotechnology |
Lelio Fellows Filho, Dalci Maria dos Santos, Gilda Massari Coelho, Márcio de Miranda Santos |
Research Paper |
2005-09 |
| End of an Era? |
Stefan Picker |
Letter from the Editor |
2006-01 |
| The Global Business of Chemistry: Prospects and Challenges |
Thomas Kevin Swift |
Commentary |
2006-01 |
| Systematically Creating Coincidental Product Evolution Case Studies of the Application of the Systematic Inventive Thinking® (SIT) Method in the Chemical Industry |
Yoni Stern, Idit Biton, Ze’ev Ma’or |
Research Paper |
2006-01 |
| The consumption of Sicilian red oranges: implications for firms involved in commercialization |
Alfonso Silvio Zarbà, Gaetano Pulvirenti |
Research Paper |
2006-01 |
| Intellectual Property: An underestimated and undermanaged asset? |
Jan Friese, Udo Jung, Thomas Röhm, Ralf Spettmann |
Practitioner’s Section |
2006-01 |
| Interdisciplinarity at Work |
Stefan Picker, Benjamin Niedergassel, Prof. Dr. Jens Leker |
Letter from the Editors |
2006-05 |
| School for the Bilingual: Dual Master’s Degrees in Business and Biotech |
Emily Waltz |
Commentary |
2006-05 |
| How Do Italian Biotechnology Startups Survive? |
Anna Nosella, Giorgio Petroni and Chiara Verbano |
Research Paper |
2006-05 |
| Detergent Phosphates: an EU Policy Assessment |
Jonathan Köhler |
Research Paper |
2006-05 |
| Chemische Fabrik Griesheim – Pioneer of Electrochemistry |
Dieter Wagner |
Practitioner’s Section |
2006-05 |
| Changes in the Chemical Industry |
Benjamin Niedergassel |
Letter from the Editor |
2006-09 |
| Dialogue on Nanotech: The South Carolina Citizens’ School of Nanotechnology |
Chris Toumey, J. Ryan Reynolds, Argiri Aggelopoulou |
Commentary |
2006-09 |
| Innovation Strategies for the Australian Chemical Industry |
Garrett Upstill, Alan J. Jones, Tom Spurling and Greg Simpson |
Research Paper |
2006-09 |
| Three-Dimensional Valuation of IP Rights |
Bernd Fabry |
Research Paper |
2006-09 |
| The Future Belongs to Renewable Resources |
Dr. Stefan Nordhoff |
Practitioner’s Section |
2006-09 |
| Struggling for profitability: not necessarily new, but challenging |
Clive-Steven Curran |
Letter from the Editor |
2007-01 |
| CeNTech - Nanotechnological Research and Application |
Kristina Riehemann, Arnold M. Raem, Wolfgang Buscher, Harald Fuchs |
Commentary |
2007-01 |
| Open Innovation: the New Way of Knowledge Transfer? |
Jan de Wit, Ben Dankbaar and Geert Vissers |
Research Paper |
2007-01 |
| A Model of Knowledge Sharing in Biomedical Engineering: Challenges and Requirements |
A.A. Arntzen-Bechina, C.A.D Leguy |
Research Paper |
2007-01 |
| Value Pricing in the Chemical Industry – Most Powerful Lever to Profitability |
Steffen Rüdiger, Clemens Elliger, Christian Weigel |
Practitioner’s Section |
2007-01 |
| Tackling present and future challenges of the chemical industry |
Benjamin Niedergassel |
Letter from the Editor |
2007-05 |
| Australian Cooperative Business |
Helmut Hügel |
Commentary |
2007-05 |
| Knowledge Management and Knowledge-based Marketing |
Yoosuf Cader |
Research Paper |
2007-05 |
| Engineering an Instrument to Evaluate Safety Critical |
G.L.L. Reniers, W. Dullaert, B.J.M. Ale, F. Verschueren, K. Soudan |
Practitioner’s Section |
2007-05 |
| Technology to Clean Up Coal for the Post-oil Era |
Joseph Auer |
Practitioner’s Section |
2007-05 |
| Exploring the wide field of business chemistry |
Clive-Steven Curran |
Letter from the Editor |
2007-09 |
| Channel management in the chemical industry - Selecting the right option |
Marc Fermont |
Commentary |
2007-09 |
| Testing Costs and Testing Capacity According to the REACH Requirements – Results of a Survey of Independent and Corporate GLP Laboratories in the EU and Switzerland |
Manfred Fleischer |
Research Paper |
2007-09 |
| Enthalpy Change: Firing Enthusiasm for learning |
Gordon Dyer |
Research Paper |
2007-09 |
| Chemical plant engineering projects – Customers around the world prefer cutting-edge technology “Made in Germany” |
Klaus Gottwald |
Practitioner’s Section |
2007-09 |
| The growing importance of covering payment risks in the Chemical Industry |
Michael Timmermann |
Practitioner’s Section |
2008-01 |
| The spatial dynamics of the European Biotech Industry- a NEG approach with vertical linkages |
Jan Kranich |
Research Section |
2008-01 |
| Patterns of collaboration along the bio-pharmaceutical innovation process |
Davide Chiaroni, Vittorio Chiesa and Federico Frattini |
Research Section |
2008-01 |
| REACh: A European chemicals regulation with global intersectoral consequences |
Daniela Valceanu |
Commentary |
2008-01 |
| The Journal of Business Chemistry – Five issues of covering the latest trends in research and practice |
Benjamin Niedergassel and Clive-Steven Curran |
Letter from the Editor |
2008-01 |
| Developments at the outposts of the Chemical Industry |
Clive-Steven Curran |
Letter from the Editor |
2008-05 |
| Unbiased insight on biopharma’s innovation crisis |
Enrique Esteban, Frank Lien and Richard Youn |
Practitioner’s Section |
2008-05 |
| A motor for future-proof jobs. The results of the study “Biotechnology in Germany - Employment potential and competitiveness” |
Edeltraud Glänzer |
Practitioner’s Section |
2008-05 |
| REACh due diligence – Extended scope of M&A services in the framework of REACh |
Bernd Schneider and Matthias Kuschel |
Commentary |
2008-05 |
| Entrepreneurial potential in chemistry and pharmacy. Results from a large survey |
Aurora A.C. Teixeira |
Research Section |
2008-05 |
| Dark clouds are gathering |
David Große Kathöfer |
Letter from the Editor |
2008-09 |
| Sector inquiry into the pharmaceutical sector |
Marc Besen and Dimitri Slobodenjuk |
Commentary |
2008-09 |
| The value based portfolio management in response to REACh – A manual of different strategies for the Chemical Industry |
Christina Feldmeier and Sebastian Kienert |
Research Section |
2008-09 |
| Beyond forecasting: Responsive supply networks |
Ray Adams |
Practitioner’s Section |
2008-09 |
| Managing the effects of the business cycle in the Chemical Industry |
Kai Pflug |
Practitioner’s Section |
2008-09 |
| Discussing challenges in the chemical industry for five years |
Stefan Picker and David Große Kathöfer |
Letter from the Editor |
2009-01 |
| The effects of the financial crisis on the future of the Chemical Industry |
Rudolf Jerrentrup |
Commentary |
2009-01 |
| Mergers & Acquisitions (M&A) in the Pharmaceutical and Chemical Industries: A lighthouse in choppy waters |
Matthias R. Hornke |
Commentary |
2009-01 |
| Open Source biopharmaceutical innovation- A mode of entry for firms in emerging markets |
Minna Allarakhia |
Research Section |
2009-01 |
| Biotechnology research in South Africa: A benchmarking exercise |
Anthipi Pouris and Anastassios Pouris |
Research Section |
2009-01 |
| REACH effects - Opportunities and risks for transfer pricing |
Andreas Boller and Markus Keerl |
Practitioner’s Section |
2009-01 |
| Thunderstorms strike the economy |
David Große Kathöfer |
Letter from the Editor |
2009-05 |
| The place of chemistry in business |
Arthur D. Little |
Historical article |
2009-05 |
| Chemists of the future |
Klaus Müllen |
Commentary |
2009-05 |
| M&A since Y2K - An overview of chemicals deals involving BRIC countries in the new millennium |
Bernd W. Schneider, Stanislav Plakun and Tim-Frederic Slooth |
Practitioner's Section |
2009-05 |
| Patent license negotiation: Best practices |
Jennifer Giordano-Coltart and Charles W. Calkins |
Practitioner's Section |
2009-05 |
| REACH and the role of stakeholders in its socio-economic analysis |
Jan Boris Ingerowski, Daniela Kölsch and Heinrich Tschochohei |
Research Section |
2009-05 |
| Assessment of thermal-stable polymer nanocomposite techniques by patent citation network analysis |
Hsin-Ning Su and Pei-Chun Lee |
Research Section |
2009-09 |
| Preparing for the time after the crisis |
David Große Kathöfer |
Letter from the Editor |
2009-09 |
| A capital market's view on Industrial Biotechnology – proper valuation is the key for picking the right investment opportunities in stormy times |
Bernd W. Schneider |
Commentary |
2009-09 |
| Feasibility of Active Ingredient (AI) development for new biocides in the EU |
Kaisa Soirinsuo, Elina Kähkönen, Jouko Karjalainen and Katrina Nordström |
Practitioner’s Section |
2009-09 |
| How to implement ‘access to medicine’ AND enhance economic performance: business model options for global access |
Jürgen Peukert and Thomas Fuggenthaler |
Practitioner’s Section |
2009-09 |
| Tiny things being huge |
Jens Leker and David Große Kathöfer |
Letter from the Editor |
2010-01 |
| Nanotechnology patenting in China and Germany - a comparison of patent landscapes by bibliographic analyses |
Nina Preschitschek and Dominic Bresser |
Research Section |
2010-01 |
| Identifying the emerging roles of nanoparticles in biosensors |
Lu Huang, Zhengchun Peng, Ying Guo and Alan L. Porter |
Research Section |
2010-01 |
| Knowledge sharing in heterogeneous collaborations - a longitudinal investigation of a cross-cultural research collaboration in nanoscience |
Steffen Kanzler |
Research Section |
2010-01 |
| Technological trajectories and multidimensional impacts: further remarks on the nanotechnology industry |
Paulo Antônio Zawislak, Luis Fernando Marques, Priscila Esteves and Fernanda Rublescki |
Research Section |
2010-01 |
| Mergers & acquisitions (M&A) in the pharmaceutical industry: the wheel keeps on turning |
Matthias Hornke and Sven Mandewirth |
Commentary |
2010-05 |
| Lessons learned or business as usual? |
David Große Kathöfer |
Letter from the Editor |
2010-05 |
| New biocide active substances: needs and challenges in the EU as viewed by industry |
Elina Kähkönen, Teemu Hirvonen and Katrina Nordström |
Research Paper |
2010-05 |
| REACH implementation costs in the Belgian food industry: a semi-qualitative study |
Genserik Reniers, Hanne Geelen, Emilie Goris and Amaryllis Audenaert |
Practitioner’s Section |
2010-05 |
| Performance improvement in pharmaceutical R&D through new outsourcing models |
Gunter Festel, Alexander Schicker and Roman Boutellier |
Practitioner’s Section |
2010-05 |
| Sustainability in the chemical and pharmaceutical industry - results of a benchmark analysis |
Jürgen Peukert and Karin Sahr |
Practitioner’s Section |
2010-05 |
| The chemical industry at the edge of change? |
David Große Kathöfer |
Letter from the Editor |
2010-09 |
| Bio products from bio refineries - trends, challenges and opportunities |
Bhima Vijayendran |
Commentary |
2010-09 |
| Analyzing the Direct Methanol Fuel Cell technology in portable applications by a historical and bibliometric analysis |
Arho Suominen and Aulis Tuominen |
Research Paper |
2010-09 |
| Multidisciplinary collaborations in pharmaceutical innovation: a two case-study comparison |
Irina Saur-Amaral and Alexander Kofinas |
Research Paper |
2010-09 |
| Pharma 3.0: delivering on health outcomes |
Patrick Flochel and Frank Kumli |
Practitioner's Section |
2010-09 |
| Industrial biotechnology becomes a key competitive factor |
Manfred Kircher |
Commentary |
2011-01 |
| Towards a phenotype of the amphibious company: an illustrative case from the chemical company |
Mattia Bianchi, Alberto Di Minin and Frederico Frattini |
Research Paper |
2011-01 |
| What's ahead in 2011? |
Sebastian Kortmann |
Letter from the Editor |
2011-01 |
| Exploring market knowledge in product development of chemical firms |
Armand Smits, Geert Vissers and Ben Dankbaar |
Research Paper |
2011-01 |
| Pricing in the crisis? An empirical analysis |
Ralf Schmidt |
Practitioner's Section |
2011-01 |
| Internationalization & Growth |
Sebastian Kortmann |
Letter from the Editor |
2011-05 |
| Optimal ambidexterity and exploration valuableness: balancing short-term and long-term trade-off in pharmaceutical products development |
Osamu Suzuki and David Methé |
Research Paper |
2011-05 |
| The challenges and opportunities of the European Union lead market initiative: case bio-based products |
Anne Toppinen and Meri Siljama |
Research Paper |
2011-05 |
| Sources of information for technology intelligence in chemical formulation |
Álvaro Pedroza Zapata and Sara Ortiz Cantú |
Practitioner’s Section |
2011-05 |
| Working capital management in the Swiss chemical industry |
Stefan Seeger, Alwin Locker and Christian Jergen |
Practitioner’s Section |
2011-05 |
| Opaque Times |
Guido Wünsche and Sebastian Kortmann |
Letter from the Editor |
2011-09 |
| R&D Spin-outs in the Pharmaceutical Industry |
Gunter Festel and Sven H. De Cleyn |
Research Paper |
2011-09 |
| Supply-Side Determinants of Energy Consumption and Efficiency (ECE) Innovations |
Kieran O’Brien and Nuttaneeya (Ann) Torugsa |
Research Paper |
2011-09 |
| Procurement in 21st century in the chemical, pharmaceutical and healthcare industry |
Thorsten Makowski and Michael Clauß |
Practitioner’s Section |
2011-09 |
| Application of Timing Option to Founding Investment Decision of Biotech Start-ups |
Takao Fujiwara |
Practitioner’s Section |
2011-09 |
| Startup of new plants and process technology in the process industries: organizing for an extreme event |
Thomas Lager |
Research Paper |
2012-02 |
| The founding angels investment model - case studies from the field of nanotechnology |
Gunter Festel and Jan Kratzer |
Research Paper |
2012-02 |
| Standardized cost estimation for new technologies (SCENT) - methodology and tool |
Stanil Y. Ereev and Martin K. Patel |
Practitioner’s Section |
2012-02 |
| Development of an effective outsourcing strategy for toxicological studies in the chemical industry |
Katja Hempel, Sandra Zumstein, Michael Graef, Hennicke Kamp and Bennard van Ravenzwaay |
Practitioner’s Section |
2012-02 |
| Spotlight on: Process Innovation Management |
Guido Wünsche and Carsten Gelhard |
Letter from the Editor |
2012-02 |
